Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Assessing safety means examining volatility, drawdown risk, and income prospects of index funds versus bonds to determine the calmer route for retirement.
23,779 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
A Portland, Oregon court filing shows Compass has settled the Murch TCPA lawsuit. The terms are confidential, and a n...
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Bitcoin hovers near a pivotal zone as bulls and bears clash. Analysts warn of a potential break below key supports, s...
A data-driven model now sees roughly 36% upside for Qualcomm stock within a year, even after a choppy period around i...
D-Wave Quantum stock swung wildly on momentum and policy headlines, then reversed hard. This guide breaks down what h...
Alpha Omega Semiconductor stock has doubled this year, but is the rally justified? This guide breaks down the busines...
SanDisk stock soared today as investors weighed memory-chip demand, rival earnings, and risk factors. This guide brea...
FuelCell Energy leads a sell-off in fuel-cell stocks as investors lock in gains after a sharp rally, while Bloom Ener...
A growing investing approach aims to fund car replacements with a dividend-driven portfolio, potentially ending auto ...
A leading analyst has reiterated a $250 SpaceX target, arguing that SpaceX's physical AI capabilities could reshape r...
A CFO's $2.1 million sale of OUSTER shares raises questions for investors. This analysis explains what such insider m...